# Pykus Therapeutics, Inc. — Form D

Pykus Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-05. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2021-02-05
- Form: D
- Accession: 0001840955-21-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.5M
- Investors: 32
- Date of first sale: 2020-12-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-388583

## Issuer

- Name: Pykus Therapeutics, Inc.
- CIK: 0001840955
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: ONE MIFFLIN PLACE, SUITE 320, CAMBRIDGE, MA, 02138
- Phone: 617-394-8960

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Carl A Berke | Director | Cambridge, MA |
| Richel P Liu | Director | Cambridge, MA |
| Sameer P Sabir | Director | Cambridge, MA |
| Michael A Singer | Director | Cambridge, MA |
| Thomas P Stryjewski | Director | Cambridge, MA |
| James A Stefater | Executive Officer | Cambridge, MA |

## More

- [CIK 1840955 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1840955&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001840955-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.